{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:04:27Z","timestamp":1761807867944},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,5,4]],"date-time":"2014-05-04T00:00:00Z","timestamp":1399161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s13277-014-1959-0","type":"journal-article","created":{"date-parts":[[2014,5,3]],"date-time":"2014-05-03T00:22:42Z","timestamp":1399076562000},"page":"7569-7574","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population"],"prefix":"10.1007","volume":"35","author":[{"given":"Junkai","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanjun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,4]]},"reference":[{"key":"1959_CR1","unstructured":"International Agency for Research on Cancer (IARC). Globocan 2008: Stomach cancer incidence, mortality and prevalence worldwide in 2008. IARC."},{"issue":"Suppl 1","key":"1959_CR2","first-page":"S4","volume":"54","author":"JS Macdonald","year":"2004","unstructured":"Macdonald JS. Clinical overview: adjuvant therapy of gastrointestinal cancer. Cancer Chemother Pharmacol. 2004;54 Suppl 1:S4\u201311.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"1959_CR3","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/annonc\/mdh422","volume":"15","author":"SS W\u00f6hrer","year":"2004","unstructured":"W\u00f6hrer SS, Raderer M, Hejna M. Palliative chemotherapy for advanced gastric cancer. Ann Oncol. 2004;15(11):1585\u201395.","journal-title":"Ann Oncol"},{"issue":"3","key":"1959_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/20014091074192","volume":"36","author":"N Tuteja","year":"2001","unstructured":"Tuteja N, Tuteja R. Unraveling DNA repair in human: molecular mechanisms and consequences of repair defect. Crit Rev Biochem Mol Biol. 2001;36(3):261\u201390.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1959_CR5","unstructured":"Kirschner K, Melton DW. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs. Anticancer Res. 2010;30(9):3223\u201332."},{"key":"1959_CR6","doi-asserted-by":"crossref","unstructured":"Arora S, Kothandapani A, Tillison K, Kalman-Maltese V, Patrick SM. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. DNA Repair (Amst). 2010;9(7):745\u201353.","DOI":"10.1016\/j.dnarep.2010.03.010"},{"issue":"17","key":"1959_CR7","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1101\/gad.15699211","volume":"25","author":"AT Wang","year":"2011","unstructured":"Wang AT, Sengerov\u00e1 B, Cattell E, et al. Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. Genes Dev. 2011;25(17):1859\u201370.","journal-title":"Genes Dev"},{"issue":"20","key":"1959_CR8","doi-asserted-by":"crossref","first-page":"9990","DOI":"10.1093\/nar\/gks818","volume":"40","author":"EM McNeil","year":"2012","unstructured":"McNeil EM, Melton DW. DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy. Nucleic Acids Res. 2012;40(20):9990\u201310004.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1959_CR9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ijrobp.2012.09.032","volume":"85","author":"A Jagdis","year":"2013","unstructured":"Jagdis A, Phan T, Klimowicz AC, et al. Assessment of ERCC1 and XPF protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients undergoing curative intent treatment. Int J Radiat Oncol Biol Phys. 2013;85(5):1340\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1959_CR10","first-page":"BR156","volume":"18","author":"J Li","year":"2012","unstructured":"Li J, Zhang J, Liu Y, Ye G. Increased expression of DNA repair gene XPF enhances resistance to hydroxycamptothecin in bladder cancer. Med Sci Monit. 2012;18(4):BR156\u201362.","journal-title":"Med Sci Monit"},{"issue":"11","key":"1959_CR11","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/sj.bjc.6605686","volume":"102","author":"KR Fareed","year":"2010","unstructured":"Fareed KR, Al-Attar A, Soomro IN, et al. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. Br J Cancer. 2010;102(11):1600\u20137.","journal-title":"Br J Cancer"},{"issue":"1","key":"1959_CR12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207\u201314.","journal-title":"Cancer"},{"issue":"5","key":"1959_CR13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/ijc.23852","volume":"124","author":"B Gustavsson","year":"2009","unstructured":"Gustavsson B, Kaiser C, Carlsson G, et al. Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes. Int J Cancer. 2009;124(5):1220\u20136.","journal-title":"Int J Cancer"},{"issue":"7","key":"1959_CR14","first-page":"515","volume":"32","author":"J Liang","year":"2010","unstructured":"Liang J, Li QF, Yao RY, et al. Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin\/5-Fu-based chemotherapy. Zhonghua Zhong Liu Za Zhi. 2010;32(7):515\u20139.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"1959_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-230X-12-137","volume":"12","author":"Z Wang","year":"2012","unstructured":"Wang Z, Chen JQ, Liu JL, Qin XG, Huang Y. Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum\/5-Fu-based chemotherapy: a systematic review. BMC Gastroenterol. 2012;12:137.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"1959_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","volume":"24","author":"E Reed","year":"1998","unstructured":"Reed E. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treat Rev. 1998;24(5):331\u201344.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"1959_CR17","first-page":"1513","volume":"11","author":"EL Goode","year":"2002","unstructured":"Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1513\u201330.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1959_CR18","doi-asserted-by":"crossref","unstructured":"Lu ZM, Luo TH, Nie MM, et al. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy. Tumour Biol. 2013 Dec 8.","DOI":"10.1007\/s13277-013-1378-7"},{"issue":"1","key":"1959_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11605-011-1700-x","volume":"16","author":"R Metzger","year":"2012","unstructured":"Metzger R, Warnecke-Eberz U, Alakus H, et al. Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis. J Gastrointest Surg. 2012;16(1):26\u201334. discussion 34.","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"1959_CR20","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/bjc.2011.24","volume":"104","author":"SR Park","year":"2011","unstructured":"Park SR, Kong SY, Nam BH, et al. CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients. Br J Cancer. 2011;104(7):1126\u201334.","journal-title":"Br J Cancer"},{"issue":"11","key":"1959_CR21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/FPC.0b013e3283653afc","volume":"23","author":"E Rumiato","year":"2013","unstructured":"Rumiato E, Cavallin F, Boldrin E, Cagol M, Alfieri R, Basso D, et al. ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin\/5-FU-based neoadjuvant therapy. Pharmacogenet Genom. 2013;23(11):597\u2013604.","journal-title":"Pharmacogenet Genom"},{"issue":"4","key":"1959_CR22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/mutage\/get023","volume":"28","author":"H Chu","year":"2013","unstructured":"Chu H, Gu D, Xu M, et al. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis. 2013;28(4):441\u20136.","journal-title":"Mutagenesis"},{"issue":"6","key":"1959_CR23","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1158\/1078-0432.CCR-10-2169","volume":"17","author":"M Yin","year":"2011","unstructured":"Yin M, Yan J, Martinez-Balibrea E, et al. ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis. Clin Cancer Res. 2011;17(6):1632\u201340.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1959_CR24","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S1097-2765(03)00478-7","volume":"12","author":"XD Zhu","year":"2003","unstructured":"Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T. ERCC1\/XPF removes the 3\u2032 overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell. 2003;12(6):1489\u201398.","journal-title":"Mol Cell"},{"issue":"3","key":"1959_CR25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijrobp.2004.11.026","volume":"62","author":"DG Kornguth","year":"2005","unstructured":"Kornguth DG, Garden AS, Zheng Y, Dahlstrom KR, Wei Q, Sturgis EM. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys. 2005;62(3):665\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1959_CR26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijrobp.2011.05.033","volume":"83","author":"BM Alexander","year":"2012","unstructured":"Alexander BM, Wang XZ, Niemierko A, et al. DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):164\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-1959-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-1959-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-1959-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T22:45:42Z","timestamp":1565390742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-1959-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,4]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1959"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-1959-0","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,4]]}}}